[188 Pages Report] The Next Generation Sequencing Market size was estimated at USD 17.73 billion in 2023 and expected to reach USD 21.38 billion in 2024, at a CAGR 23.61% to reach USD 78.21 billion by 2030.
Next-generation sequencing (NGS) is the parallel sequencing technology that delivers ultra-high throughput, scalability, and speed. The technology is operated to determine the order of nucleotides in whole genomes or targeted regions of DNA or RNA. This high-throughput technique defines a part of the nucleotide sequence of an individual's genome that utilizes DNA sequencing technologies capable of processing multiple DNA sequences in parallel. Governments worldwide strive to keep healthcare expenditure affordable while providing equal access to high-quality care, leading to increased awareness and adoption of clinical diagnostics among patients, such as NGS technology. Growing technological developments in NGS instruments and technologies and rising adoption by the agriculture sector are driving the market growth. However, privacy concerns regarding next-generation sequencing data protection and a need for computation resources for next-generation sequencing hamper market growth. Continuous technological development of NGS products and government support and initiatives are expected to create significant market opportunities in the future.
The Americas is a significant market in next-generation sequencing owing to the increasing number of research projects, rising demand for new NGS platforms, and growing use of NGS consumables projected market development. With high R&D investment and the availability of a technologically developed healthcare research framework, the development of whole genome sequencing (WGS) in the region is a critical factor for the market's growth. In Europe, increasing usage of NGS in the centers performing ground-level research and rising development and advancement in research in sequencing have created a significant expansion in the region. In the Asia-Pacific, the market is estimated to grow rapidly over the forecast period owing to the presence of substantial developments by China and Japan for technological integration of NGS methodologies and the development of healthcare, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia-Pacific NGS market to witness lucrative opportunities of expansion.
The FPNV Positioning Matrix is pivotal in evaluating the Next Generation Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next Generation Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies.
QIAGEN, a global leading provider of Sample to Insight molecular diagnostic and research solutions, has completed its acquisition of Verogen, a leader in human identification and forensic genomics with Next Generation Sequencing (NGS) technologies. With this strategic move, QIAGEN aims to strengthen its leadership position in human identification and forensic science by expanding its portfolio of NGS-based solutions. The company's commitment to investing in the development of NGS verticals reinforces its dedication to providing high-quality, cutting-edge solutions to the forensic community. The acquisition of Verogen is a critical milestone in QIAGEN's quest to revolutionize human diagnostics and research. The synergies generated by combining the two companies' strengths in biotechnology and data analysis are sure to have a profound impact on the forensic and human identification industry. [Published On: 2023-01-09]
QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases.
QIAGEN and Helix have announced an exclusive partnership to advance the production of Next Generation Sequencing (NGS) Companion Diagnostics for hereditary diseases. This collaboration merges Helix’s scalable NGS platform with QIAGEN’s proprietary bioinformatics solutions to create a comprehensive diagnostics offering for precision medicine. With hereditary diseases affecting millions of people worldwide, this partnership holds great promise in expanding the reach and accessibility of personalized healthcare. Both QIAGEN and Helix bring their expertise and resources to this collaboration, highlighting a commitment to advancing the field of genomics through innovative partnerships. [Published On: 2023-01-05]
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research.
Agilent, a leading life sciences company, has recently announced their acquisition of Avida Biomed, a developer of high-performance NGS target enrichment workflows for cancer research. This acquisition will allow Agilent to expand their offerings in the rapidly growing market of Next Generation Sequencing (NGS). NGS technology has revolutionized the field of genomics, allowing for faster and more accurate analysis of DNA and RNA sequences, which has been invaluable in cancer research. With this acquisition, Agilent is reaffirming their commitment to providing researchers with powerful tools to accelerate scientific discovery and improve patient outcomes. [Published On: 2023-01-04]
The report delves into recent significant developments in the Next Generation Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., ATDBio Ltd., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BIO3 SCIENTIFIC SDN BHD, bioMerieux S.A., BioVendor–Laboratorní medicína a.s, Cambridge Bioscience Limited, CD Genomics, CeGaT GmbH, Charles River Laboratories, Inc., DNAnexus, Inc., DNASTAR, Inc., ELEMENT BIOSCIENCES, Enzo Life Sciences, Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fraunhofer-Gesellschaft, GENEWIZ, Genomatix, GenPath, GenScript Biotech Corporation, GRAIL, LLC, Hamilton Company, Illumina, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., iRepertoire, Inc., LabMal, Macrogen, Inc., Medigene Sdn Bhd., Merck KGaA, NanoString Technologies, Inc., Neoscience, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PathoQuest, PCR Biosystems Ltd., Perkin Elmer, Inc., Promega Corporation, PT Pandu Biosains, Qiagen N.V., Resolution Bioscience, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..
This research report categorizes the Next Generation Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Technology
- Targeted Sequencing & Re-Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Product Type
- Consumables
- Platforms
- Services
- Application
- Agriculture
- Animal science & Veterinary Research
- Diagnostics
- Drug Discovery
- End User
- Academic & Research Institutes
- Clinical Laboratories
- Contract Research Organization
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Next Generation Sequencing Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next Generation Sequencing Market?
- What are the technology trends and regulatory frameworks in the Next Generation Sequencing Market?
- What is the market share of the leading vendors in the Next Generation Sequencing Market?
- Which modes and strategic moves are suitable for entering the Next Generation Sequencing Market?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Next Generation Sequencing Market, by Technology
- Next Generation Sequencing Market, by Product Type
- Next Generation Sequencing Market, by Application
- Next Generation Sequencing Market, by End User
- Americas Next Generation Sequencing Market
- Asia-Pacific Next Generation Sequencing Market
- Europe, Middle East & Africa Next Generation Sequencing Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 24]
- List of Tables [Total: 382]
- List of Companies Mentioned [Total: 48]
Analyzing Plant Genomes:
With NGS technology, the sequencing of an entire plant genome can be completed in a few weeks, which previously took years. Sequencing enables us to identify the location of specific genes and mutations within the DNA that gives rise to particular plant traits. For instance, sequencing can predict disease resistance by examining alleles that confer resistance. With this information, agricultural scientists can find ways to develop more disease-resistant crops, which could translate into better yields and a more uniform production system. The ability to sequence plants quickly and accurately using NGS technology is an incredible achievement for the plant breeding industry.
Identifying Genetic Markers:
One of the most significant benefits of NGS technology in agriculture is identifying genetic markers specific to plant characteristics. We can create custom plant varieties that meet specific needs by identifying genetic markers associated with traits like sugar content, drought tolerance, and disease resistance. By using these genetic markers, breeders can breed plants with the required attributes and avoid wasting time and resources on plants that do not meet the requirements. The use of NGS technology in agriculture is, therefore, likely to reduce the development time of new crop varieties and also contribute to the production of more resilient crops.
Tracking Disease and Pests:
NGS technology can also be used to track pathogen transmission and identify disease outbreaks in plants. Pathogens can move from one region to another via wind, water, and other environmental factors. By identifying the location of pathogen DNA, NGS technology can help determine the origin of an outbreak, giving farmers time to take appropriate preventative measures. In addition, NGS technology can also help identify isolated cases offering new opportunities to fight outbreaks and protect our crops.
Nutrigenomics:
Another application of NGS technology in agriculture is the analysis of gene expression in crops. Nutrigenomics studies identify the impact of nutrients or bioactive compounds in the diet on the expression of an individual's genome. Genomics is considered a unique approach to understanding the interactions between dietary compounds and human health. A similar approach in agronomy would help identify how we can optimize the nutrient content of our crops to support population health.
Precision Agriculture:
NGS technology in agriculture can also support precision agriculture. The detailed plant genomic data enables farmers to optimize inputs while minimizing unintended environmental effects. It brings together mapping, sensors, IoT, drones, and the use of genomic data to increase our ability to understand how plants interact with the environment and how precision agriculture can be employed.
The use of NGS technology in agriculture has revolutionized the industry by enabling large-scale genomic analysis, the identification of specific genetic markers, and disease tracking. The benefits of NGS technology are vast for the agriculture industry, including faster crop development, disease tracking, customized breeding programs, improved yield, and better environmental management. With the technology continuing to advance, we can expect to see more innovative applications for NGS in the future and an even bigger impact on agriculture.
- How big is the Next Generation Sequencing Market?
- What is the Next Generation Sequencing Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?